| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Baudax Bio, Inc. | President and CEO, Director | Common Stock | 2.43K | $6.18K | $2.55 | Dec 15, 2022 | Direct |
| Baudax Bio, Inc. | President and CEO, Director | Common Stock | 14 | $35.70 | $2.55 | Dec 15, 2022 | By spouse |
| Recro Pharma, Inc. | Director | Stock Option (right to buy) | 38K | Apr 20, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BXRX | Baudax Bio, Inc. | Dec 15, 2022 | 1 | $3.06K | 4 | Dec 19, 2022 | President and CEO, Director |
| BXRX | Baudax Bio, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | President and CEO, Director |
| BXRX | Baudax Bio, Inc. | Dec 15, 2021 | 2 | -$5.78K | 4 | Dec 23, 2021 | President and CEO, Director |
| BXRX | Baudax Bio, Inc. | Dec 5, 2021 | 1 | -$3.2K | 4 | Dec 14, 2021 | President and CEO, Director |
| BXRX | Baudax Bio, Inc. | Sep 22, 2021 | 1 | $4.8K | 4 | Sep 23, 2021 | President and CEO, Director |
| BXRX | Baudax Bio, Inc. | May 7, 2021 | 1 | $4.99K | 4 | May 10, 2021 | President and CEO, Director |
| SCTL | Recro Pharma, Inc. | Apr 20, 2021 | 1 | $0 | 4/A | May 17, 2021 | Director |